AtonRa Partners’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $229K | Sell |
7,502
-868
| -10% | -$26.5K | 0.46% | 101 |
|
|
2023
Q3 | $265K | Sell |
8,370
-1,804
| -18% | -$57K | 0.56% | 89 |
|
|
2023
Q2 | $415K | Sell |
10,174
-713
| -7% | -$29.1K | 0.64% | 73 |
|
|
2023
Q1 | $406K | Sell |
10,887
-1,445
| -12% | -$53.9K | 0.59% | 78 |
|
|
2022
Q4 | $430K | Sell |
12,332
-4,552
| -27% | -$159K | 0.55% | 79 |
|
|
2022
Q3 | $945K | Buy |
16,884
+114
| +0.7% | +$6.38K | 0.93% | 45 |
|
|
2022
Q2 | $868K | Sell |
16,770
-3,210
| -16% | -$166K | 0.8% | 53 |
|
|
2022
Q1 | $1.45M | Sell |
19,980
-9,606
| -32% | -$698K | 0.79% | 54 |
|
|
2021
Q4 | $3.5M | Buy |
29,586
+3,433
| +13% | +$406K | 1.22% | 27 |
|
|
2021
Q3 | $3.51M | Buy |
26,153
+6,477
| +33% | +$869K | 1.17% | 29 |
|
|
2021
Q2 | $3.19M | Buy |
19,676
+8,546
| +77% | +$1.38M | 1.17% | 31 |
|
|
2021
Q1 | $893K | Buy |
+11,130
| New | +$893K | 0.4% | 96 |
|